Company intelligence / Profile preview

Hoechst Roussel Vet

Wiesbaden, Hesse, Germany

Ownership: Private
Employees: ~2500
Development stage: Other

Overview

Hoechst Roussel Vet was a leading global animal health company that specialized in the development, manufacturing, and marketing of veterinary pharmaceuticals and vaccines. The company provided a wide range of products for livestock and companion animals, including anti-infectives, antiparasitics, and reproductive hormones. In 1999, it was acquired by Akzo Nobel and merged with Intervet to form one of the world's largest animal health entities. Today, its legacy products and operations are integrated into MSD Animal Health, following subsequent industry consolidations involving Schering-Plough and Merck & Co.

Therapeutic areas: DermatologyInfectious Diseases
Modalities: Small moleculeVaccineBiologic
Industry: Veterinary

Beyond the preview

Go deeper on Hoechst Roussel Vet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hoechst Roussel Vet.

Explore the full profile